New Adjuvant Treatment Strategies for Early-Stage HER2-Positive Breast Cancer: Clinical and Shared Decision Making Implications for the Oncology Nurse

Review an expert-led Webcast, downloadable slides, and a pocket guide to get up to date on optimal nursing care of patients receiving adjuvant therapy for early-stage HER2-positive breast cancer.

Downloadable Slideset

These downloadable slides, from our live meeting series on adjuvant therapy for HER2+ EBC, review the current clinical rational and most recent data on dual HER2-targeted adjuvant therapy with trastuzumab and pertuzumab as well as the use of extended therapy with neratinib for patients at high risk of disease recurrence.

Released: April 19, 2018

Resource Guide

Download this pocket guide for a summary of the optimal use of dual HER2-targeted adjuvant therapy with trastuzumab and pertuzumab as well as the use of extended therapy with neratinib for patients with HER2+ EBC at high risk of disease recurrence.

Released: April 18, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

This activity is supported by educational grants from
Genentech
Puma Biotechnology

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?